In the BioHarmony Drug Report Database

"Preview" Icon

Propantheline

Pro-banthine (propantheline) is a small molecule pharmaceutical. Propantheline was first approved as Pro-banthine on 1982-01-01. It is used to treat irritable bowel syndrome, pancreatitis, peptic ulcer, spasm, and urethral diseases amongst others in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M1, and muscarinic acetylcholine receptor M3. In addition, it is known to target muscarinic acetylcholine receptor M4.

 

Trade Name

 

Pro-banthine
 

Common Name

 

propantheline
 

ChEMBL ID

 

CHEMBL1180725
 

Indication

 

irritable bowel syndrome, pancreatitis, peptic ulcer, spasm, urethral diseases, urinary bladder diseases
 

Drug Class

 

Image (chem structure or protein)

Propantheline structure rendering